All News
STAT+: Otsuka tops Vera Therapeutics in kidney disease study showdown
An Otsuka drug succeeded in a Phase 3 study in a chronic kidney disease, with results that outperformed a competitor's recent data.
Read MoreIIT Guwahati uses clay sedimentation to measure amount of SARS-CoV-2
The research team found that a Coronavirus surrogate and Infectious Bronchitis Virus (IBV) bind to the negatively charged clay surfaces at a controlled room temperature and a neutral pH of 7
Read MoreDoctors Were Preparing to Remove Their Organs. Then They Woke Up.
A federal investigation found a Kentucky nonprofit pushed hospital workers toward surgery despite signs of revival in patients.
Read MoreAsthma Sufferers Could Be at Greater Risk if Trump Cuts Health Program
The Trump administration wants to shutter the CDC’s National Asthma Control Program, which provides millions in funding to state-administered initiatives aimed at fighting the disease.
Read MoreSTAT+: Senate GOP eyes Medicare Advantage reforms as a way to pay for tax cuts
Senators see a crackdown on Medicare Advantage upcoding as a potential way to generate savings.
Read MoreOpinion: A medical forensic nurse’s concerns about at-home sexual assault kits
After becoming popular in the wake of the Me Too movement, at-home sexual assault kits are still facing legal battles. Things could get more complicated after an FDA move.
Read MoreOpinion: We set out to quantify U.S. academic contributions to medicines. The results stunned even us
From 2020 to 2024, universities contributed patents underpinning 50% of FDA-approved drugs. 87% of those academic breakthroughs came from American institutions.
Read MorePulsed field ablation devices face growth challenges as US tariffs disrupt cardiovascular market, says GlobalData
The market is set to grow at a CAGR of 31.65 per cent from 2024 to 2034.
Read MoreHealthKois launches $ 300 Mn fund to stir growth in health landscape
Over the next four years, the firm will invest between $ 7 million to $ 25 million per company in early growth-stage businesses operating across HealthTech, Life Sciences, MedTech, Healthcare Delivery
Read MoreNHS England to give urgent help away from A&E to cut ‘corridor care’
Move is part of £450m Wes Streeting plan to tackle long delays and end hospital overcrowding Hundreds of thousands of patients needing urgent medical help will be treated in settings other than A&
Read More